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The incidence of carotid body tumors (CBTs) is
approximately one in 30,000. Of the cases, 20%
appear to be familial. There is an extremely low
probability that two sporadic cases will occur in
closely related subjects. Reports of kindred studies
on familial CBTs first began in the 1930s.1 Case
reports occurred infrequently in the next several
decades, and only recently (in the 1990s) have inves-
tigators been at the forefront of gene localization.
Although familial CBTs are rare, their presence
offers an ideal opportunity for screening adult mem-
bers of the patient’s family, leading to early diagno-
sis and treatment of tumors. Several studies suggest
autosomal dominance with complete penetrance as a
mode of genetic transmission. Recent reports con-
firm that transmission is paternally directed in famil-
ial syndromes of multiple paragangliomas.2-4 Our
experience involved a family, which spanned three
generations, with familial CBTs. We examined
tumor characteristics, family genetics, and manage-
ment issues from the literature.
METHODS
Three generations of a family with CBTs were
studied. The family tree is shown in Fig 1. All second
and third generation adult patients underwent high-
resolution computed tomography (CT) of the neck
and a physical examination. Urinary catecholamine
studies were obtained preoperatively in three of the
five patients operated on as part of an assessment for
pheochromocytoma, a tumor recently demonstrated
to have concurrence with familial CBTs.5,6
RESULTS
No pathologic tissue diagnoses for CBT could
be made in either the matriarch or patriarch of this
family. The father died of a myocardial infarction at
the age of 37 years and was described as a robust
man with a 17.5-in neck. The mother had a slender
build and died at the age of 76 years of carcinoma
of the breast. According to family members, nei-
ther parent exhibited symptoms or signs of meta-
bolically active tumors. From discussions with
members of the family and because of the apparent
lack of cranial nerve involvement, either parent
may have had a CBT, although the father is the
most likely carrier. 
The parents of the family had seven children,
four of whom have CBTs (57%). Pathologic speci-
mens of these tumors have uniformly confirmed the
tissue diagnosis. Three children in the second gener-
ation show no clinical or radiographic evidence of
tumors. No evidence of tumors was shown by means
of CT in the children (third generation) of these
three offspring either. 
In the second generation, three of the four mem-
bers who have tumors have had children. One
woman (SG) has a 2-year-old son with no clinical
signs of a neck mass. Another woman (MP) has four
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children between the ages of 23 and 34 years. These
offspring demonstrate no evidence of tumor, either
clinically or by means of CT. Therefore, at present,
neither woman with a proven CBT has transmitted
this disease in our population. One woman (SG) has
a male child who is too young for a tumor to have
developed. A second-generation male family mem-
ber (HH) has never been married or produced off-
spring, and the fourth sibling (FH), a second-gener-
ation family member, is a man with three children,
one of whom has a CBT. One of his offspring died
as a child. This boy did not have clinical evidence of
a neck mass before death. 
Of the five patients with CBTs in this family, three
have bilateral disease and three have multiple para-
gangliomas on one side. CBTs are combined with
glomus tumors in these three patients. CT studies of
one patient with bilateral CBTs are shown in Fig 2.
No clinical evidence of malignant disease was
found at the time of exploration of the neck in any of
our patients. In three of seven resections, enlarged
regional nodes in the field of dissection were negative
for neoplasm. To date, no patient has demonstrated
recurrent or metastatic disease at various intervals from
8 months to 16 years. Follow-up CT studies were
obtained 6 months postoperatively. Radiographic eval-
uation for metastatic disease has also been negative.
Three children of the second generation have no
CBTs. Their offspring have been screened compre-
hensively by means of physical examination and CT.
No CBTs have been found in the offspring of the
parents with CT-negative results, suggesting incom-
plete penetrance.
SURGICAL OUTCOMES
Seven operations have been performed on five
patients in this family. Six operations were per-
formed by one surgeon at the Lahey Clinic Medical
Center within an 18-month period. One patient was
operated on 15 years earlier by a surgeon in Maine.
Paraganglioma was revealed by means of histologic
examination on all surgical specimens. Six patients
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Fig 1.  Family tree of members of a family with a history of carotid body tumors. B, Bilateral
carotid body tumors; M, multiple paragangliomas (noncarotid body tumor); U, unilateral
carotid body tumor. It is not clinically or radiographically confirmed that FH1, the patriarch of
the family, had a carotid body tumor, but it is strongly suspected. See the methods section of the
paper for discussion. RB may have had a carotid body tumor, but her husband is speculated to
have had the derivative gene. See methods section for discussion.
required hospital admission for at least 1 day, and
one patient underwent the procedure as an outpa-
tient. No patient required transfusion of blood
products as a result of the operation. All patients had
uncomplicated recoveries. 
A transient cranial nerve injury occurred in a 49-
year-old man during resection of two tumors
extending to the base of the skull (Fig 3). The more
cephalad glomus tumor was intimately associated
with the 9th, 10th, and 12th cranial nerves, causing
the vagus nerve to be splayed over the neoplasm.
Essentially no bundles of fibers were seen under
loupe magnification. The vagus nerve was sacrificed
during resection of the tumor. Postoperatively, this
patient demonstrated increased hoarseness and a
mild swallowing disorder by means of otolaryngo-
logic evaluation and barium swallow. He was dis-
charged from the hospital on postoperative day 4
and was able to eat a regular diet.
Thus far, no tumor recurrences have been noted
by means of physical examination or follow-up CT
in our patient population. 
DISCUSSION
CBTs were first described histologically in
1891.7 Since then, reports of the familial occurrence
of CBT appear scattered throughout the literature.
Most studies represent a small number of patients,
and some do not include results of pathologic or
radiographic examination of subjects. Early attempts
at removal included resection of the carotid vessels
and were associated with high morbidity. It was
reported8 that Scudder, in 1903, was the first
American to perform successful resection of a CBT,
leaving the carotid vessels functionally intact. The
technique of surgical extirpation has undergone
modification since then, but the principles of pre-
serving the carotid bifurcation and avoiding nerve
injury have remained primary concerns for surgeons
dealing with these tumors.
Technical considerations during resection of a
CBT include adherence to nerves and vessels, con-
sideration of neovascularity of the tumor and sur-
rounding tissues, and attention to cephalad exten-
sion into regions of difficult exposure. In general,
large tumors involving the vagus and hypoglossal
nerves are more problematic for the surgeon. For
this reason, these tumors should be diagnosed early
to facilitate definitive surgical treatment. This strate-
gy lessens the likelihood of injury to cranial nerves.
Several methods are currently used as a means of
screening for CBTs. Among these tests, ultrasonog-
raphy, CT, and magnetic resonance imaging are the
most widely used. Moreover, serum testing may
soon be available as a means of identifying patients
who carry the gene for familial CBT. This would
identify patients in whom a tumor would likely
develop versus patients who could be excluded with
a high probability.
The decision when to screen a patient for famil-
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Fig 2. Computed tomography scan of patient with bilat-
eral carotid body tumors.
Fig 3. Cerebral arteriogram of a patient with multiple
tumors extending to the base of the skull.
ial CBT is not clear cut. One large study8 involving
90 patients with CBTs (sporadic) that were clinical-
ly apparent found that the youngest patient was 12
years old. In our literature search, we did not find
familial CBT occurring before this age. In our study,
the youngest family member was a 29-year-old
woman with bilateral tumors. These tumors were
sizable and clinically apparent at the time of diagno-
sis. We have somewhat arbitrarily chosen adulthood
(18 years) as a cutoff point for aggressively pursuing
the diagnosis of CBT. In some instances, however,
we would advocate earlier screening for subclinical
tumors with the imaging modalities described. We
believe that genetic counseling and physical exami-
nation are appropriate for all members of a family
with a history of CBTs. 
Although ultrasonography may be the most
common and  cost-effective tool for the screening of
CBTs, we believe that high-resolution CT offers
some advantages. We have chosen it as our inves-
tigative method of choice in this study. When con-
sidering surgical treatment of CBT in the asympto-
matic patient, estimation of the potential risk for
nerve involvement becomes crucial. Duplex scan-
ning is a sensitive means of identifying a hypervascu-
lar mass at the carotid bifurcation, but CT is a bet-
ter means of delineating the relationship of these
tumors to important structures (nerves and vessels)
and showing proximity to the base of the skull.
These measurements can be used to estimate poten-
tial morbidity and difficulty surrounding surgical
resection. Thus, CT is more than a screening tool; it
is a thorough evaluative method in our patients.
Recently, Austrian investigators9 introduced a
management strategy for CBTs that included ultra-
sonography for screening. Angiography, CT, or
magnetic resonance imaging is also advocated for
further definition (ie, proximal extension), and
angioembolization is advocated as a means of facili-
tating surgical resection. Although this approach is
thorough, we believe that in many cases preoperative
embolization is unnecessary for safe resection. 
In the family we studied, all three generations
with CBTs have lived in central Maine, essentially a
community at sea level. None of our family members
have had significant cyanotic heart disease or severe
chronic obstructive pulmonary disease. Several
investigators10,11 noted that hypoxemic stimuli (ie,
chronic obstructive pulmonary disease, living at high
altitude) may be associated with both hyperplasia
and neoplasia of the carotid body. We found no such
association in the family we studied.
Family members showed many characteristics
similar to previously reported kindred studies. We
noted a high incidence (60%) of bilaterality. In their
epidemiologic review, Grufferman et al12 described
an incidence of 31.8%. Three of our five patients
with CBTs also had associated glomus tumors. The
reported high incidence of associated glomus
tumors may reflect the sensitivity of the preoperative
imaging (high-resolution CT) strategy. 
The incidence of malignant tumors occurring in
the setting of familial syndromes is estimated at
2.5%.12 van der May et al2 compiled data from 15
families with multiple paragangliomas and found
that none of the tumors were malignant. Although
we do not offer long-term data on four of the five
family members, we did not find any evidence of
metastatic or recurrent disease during the follow-up
period (maximum time, 16 years) with CT and phys-
ical examination.
Although a simple autosomal dominant mode of
genetic transmission is commonly accepted for
familial CBTs, a paternally derived gene for multiple
paraganglioma syndrome has recently been intro-
duced. In 1989, van der Mey et al2 proposed a
paternally directed genetic transmission theory of
genomic imprinting. This male-to-male transmission
theory is consistent with our CBT population genet-
ics. CBTs often become clinically apparent in the
second to fifth decades of life, which may explain
how the patriarch of our family, a 37-year-old man
(FH1), with the body habitus described, may have
had an occult neck mass. The mechanism of genom-
ic imprinting was again described by Heutink et al3
in 1992. Although this genetic pattern of transmis-
sion for CBTs is in general agreement with our data,
we recognize that only one of two daughters has
produced children old enough to be considered for
the development of CBTs. Because we do not have
direct evidence that the father of these women had a
CBT, our data only weakly support the theory of a
paternally derived gene. We identified four CBTs in
two young patients, aged 30 and 38 years, and have
taken an aggressive approach in operating during the
asymptomatic period. Small tumors and nonathero-
sclerotic carotid vessels offer the least potential for
significant morbidity and the best possibility for
cure. Invasive (angiographic) evaluation is not
mandatory for these patients, and operative planning
can be based on the results of CT. 
Until recently, the decision to operate on patients
with CBTs was based on symptoms and clinical
examination. Today,  high-resolution CT has been a
means of screening for small and subclinical tumors.
CT is an accurate test for the detection of CBTs,
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enabling the clinician to rule out tumors or to yield
the necessary information to perform a safe and suc-
cessful operation. Our strategy is to reserve angiog-
raphy for large tumors that may cause distortion of
anatomy or extend to the base of the skull and for
patients with atherosclerosis. Angioembolization is
not necessary to avoid significant intraoperative
blood loss; none of our patients required transfusion.
This technology is associated with potential risk and,
in our experience, may not be necessary.
CONCLUSION
Familial CBTs are rare, but the characteristics of
this “syndrome” have become more clearly defined.
Specifically, we observed a high incidence of bilater-
ality and, thus far, no malignancies. The genetic
mode of transmission appears to be autosomal dom-
inance with complete penetrance, and our popula-
tion genetics may support the recently described
theory of paternally derived genomic imprinting for
familial paraganglioma syndromes. With CT imag-
ing techniques, the opportunity for earlier diagnosis
and definitive surgical treatment is facilitated.
Physical examination and high-resolution CT afford
a satisfactory screening strategy for young adults in
families with a history of this tumor.
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